Human Clinical Trials Confirm Mulbalance® Mulberry Leaf Extract Efficacy in Body Fat and Blood Lipid Management

Striving for excellence and backing it up with science. 

Following our previous human clinical trial on blood glucose management, ACE Biotechnology has reached another major milestone in product research and development: a new human clinical trial evaluating the efficacy of Mulbalance® Mulberry Leaf Extract，led by an independent third-party clinical laboratory，has concluded with resounding success, with all primary endpoints achieving statistical significance.

To comprehensively evaluate the actual performance of the product, this rigorous trial spanned 8 weeks and tracked multi-dimensional physiological indicators across 76 participants. The trial results are as follows:

l Body Fat Mass: Decreased by an average of 1.09kg

l Subcutaneous Fat Thickness：Decreased by 1.68mm

l Body Weight: Decreased by an average of 0.99kg

l Waist Circumference: Decreased by an average of 1.22cm

l Hip Circumference: Decreased by an average of 0.47cm

l BMI: Decreased by an average of 0.38

l TG:  Decreased by 0.18mmol/L

l LDL-C: Decreased by 0.17mmol/L

l TC & HDL-C: Remained stable with no adverse fluctuations.

l High Tolerability & Safety: Exhibited excellent biocompatibility with no adverse events reported throughout the study duration.

This breakthrough achievement further validates the robust, evidence-based efficacy of ACE Biotechnology’s botanical extract. And our mission is to become our business partners’first choice that is reliable, innovative, competitive and continually-improving.

Explore Product Details and Discover Science-Backed Wellness.